EBErik Bathoorn

Erik Bathoorn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erik Bathoorn has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • David J. Hetem

    Department of Clinical Microbiology, University Medical Center, Utrecht, The Netherlands

    1 shared publication
  • Hans de Cock

    Microbiology, Utrecht University, Utrecht, the Netherlands

    1 shared publication
  • Jeriela Alphenaar

    Department of Clinical Microbiology, University Medical Center, Utrecht, The Netherlands

    1 shared publication
  • Johannes G. Kusters

    Department of Clinical Microbiology, University Medical Center, Utrecht, The Netherlands

    1 shared publication
  • Marc J. M. Bonten

    Department of Clinical Microbiology, University Medical Center, Utrecht, The Netherlands

    1 shared publication
  • Martin Meijer

    Applied and Industrial Mycology/Identification Service, CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report

    by Erik Bathoorn, Natalia Escobar Salazar, Shahrzad Sepehrkhouy, Martin Meijer, Hans de Cock, Pieter-Jan Haas

    Aspergillus tubingensis is a black Aspergillus belonging to the Aspergillus section Nigri, which includes species that morphologically resemble Aspergillus niger. Recent developments in species determination have resulted in clinical isolates presumed to be Aspergillus niger being reclassified as Aspergillus tubingensis by sequencing. We present a report of a patient with an osteomyelitis of the maxillary bone with a probable invasive Aspergillus tubingensis infection.


  • Emergence of High-Level Mupirocin Resistance in Coagulase-Negative Staphylococci Associated with Increased Short-Term Mupirocin Use

    by Erik Bathoorn, David J. Hetem, Jeriela Alphenaar, Johannes G. Kusters, Marc J. M. Bonten

    In our hospital, mupirocin has increasingly been used for peri-operative decolonization of Staphylococcus aureus . The target for mupirocin is isoleucyl tRNA synthetase ( ileS ). High-level resistance to mupirocin is conferred by acquisition of plasmids expressing a distinct ileS gene ( ileS2 ). Here we evaluated the longitudinal trends in high-level mupirocin resistance in coagulase-negative staphylococci (CoNS) and linked this to the presence of ileS2 genes and mupirocin use. We assessed mupirocin resistance in CoNS bloodstream isolates from 2006 to 2011 tested by Phoenix automated testing (PAT). We evaluated the reliability of PAT results using Etest. PAT species determination was confirmed by MALDI-TOF (matrix-assisted laser desorption ionization–time of flight) mass spectrometry. We investigated the presence of ileS2 in the first 100 consecutive CoNS bloodstream isolates of each year using RT-PCR. Mupirocin use increased from 3.6 kg/year in 2006 to 13.3 kg/year in 2010 and correlated with the increase in the percentage of CoNS isolates carrying ileS2 (8% in 2006 to 22% in 2011; Spearman's rho, 0.137; P = 0.01). The sensitivity and specificity of PAT for detecting high-level mupirocin resistance were 0.97 and 0.97, respectively. ileS2 was detected in 81 of 82 phenotypically highly mupirocin-resistant strains and associated with resistance to ciprofloxacin, erythromycin, and clindamycin. In conclusion, we found a rapid increase in high-level resistance to mupirocin and resistance to other antibiotics in CoNS associated with an increase in mupirocin use. The associated resistance to other antibiotics may result in a reduction of oral antibiotic options for prolonged treatment of prosthetic infections with CoNS.